Punch & Associates Investment Management’s Hormel Foods HRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-111,598
| Closed | -$5.75M | – | 239 |
|
|
2022
Q1 | $5.75M | Buy |
111,598
+2,746
| +3% | +$135K | 0.33% | 124 |
|
|
2021
Q4 | $5.31M | Buy |
108,852
+888
| +0.8% | +$38.9K | 0.28% | 127 |
|
|
2021
Q3 | $4.43M | Sell |
107,964
-89
| -0.1% | -$4.01K | 0.25% | 142 |
|
|
2021
Q2 | $5.16M | Sell |
108,053
-232
| -0.2% | -$11K | 0.29% | 129 |
|
|
2021
Q1 | $5.17M | Buy |
108,285
+1,343
| +1% | +$63.5K | 0.31% | 128 |
|
|
2020
Q4 | $4.99M | Sell |
106,942
-2,646
| -2% | -$129K | 0.35% | 116 |
|
|
2020
Q3 | $5.36M | Sell |
109,588
-1,439
| -1% | -$72.2K | 0.46% | 92 |
|
|
2020
Q2 | $5.36M | Sell |
111,027
-779
| -0.7% | -$37.2K | 0.48% | 87 |
|
|
2020
Q1 | $5.21M | Buy |
111,806
+1,595
| +1% | +$72.5K | 0.62% | 62 |
|
|
2019
Q4 | $4.97M | Sell |
110,211
-2,994
| -3% | -$129K | 0.39% | 101 |
|
|
2019
Q3 | $4.95M | Sell |
113,205
-1,314
| -1% | -$55.2K | 0.41% | 98 |
|
|
2019
Q2 | $4.64M | Buy |
114,519
+1,240
| +1% | +$50.3K | 0.39% | 105 |
|
|
2019
Q1 | $5.07M | Buy |
113,279
+2,800
| +3% | +$120K | 0.43% | 102 |
|
|
2018
Q4 | $4.71M | Sell |
110,479
-1,074
| -1% | -$46.3K | 0.45% | 93 |
|
|
2018
Q3 | $4.39M | Buy |
111,553
+5,454
| +5% | +$209K | 0.35% | 119 |
|
|
2018
Q2 | $3.95M | Sell |
106,099
-1,878
| -2% | -$67.4K | 0.33% | 125 |
|
|
2018
Q1 | $3.71M | Sell |
107,977
-1,749
| -2% | -$59.3K | 0.33% | 128 |
|
|
2017
Q4 | $3.99M | Sell |
109,726
-1,957
| -2% | -$65.8K | 0.35% | 120 |
|
|
2017
Q3 | $3.59M | Sell |
111,683
-729
| -0.6% | -$23.8K | 0.32% | 126 |
|
|
2017
Q2 | $3.83M | Sell |
112,412
-2,082
| -2% | -$71.7K | 0.36% | 117 |
|
|
2017
Q1 | $3.96M | Buy |
114,494
+561
| +0.5% | +$20K | 0.38% | 117 |
|
|
2016
Q4 | $3.97M | Buy |
113,933
+883
| +0.8% | +$31.9K | 0.39% | 111 |
|
|
2016
Q3 | $4.29M | Buy |
113,050
+1,502
| +1% | +$55.8K | 0.46% | 90 |
|
|
2016
Q2 | $4.08M | Buy |
111,548
+2,362
| +2% | +$88.3K | 0.47% | 89 |
|
|
2016
Q1 | $4.72M | Sell |
109,186
-38,456
| -26% | -$1.6M | 0.57% | 73 |
|
|
2015
Q4 | $5.84M | Buy |
147,642
+15,996
| +12% | +$569K | 0.71% | 50 |
|
|
2015
Q3 | $4.17M | Buy |
131,646
+3,032
| +2% | +$90.9K | 0.57% | 70 |
|
|
2015
Q2 | $3.63M | Buy |
128,614
+1,256
| +1% | +$35.6K | 0.46% | 87 |
|
|
2015
Q1 | $3.62M | Sell |
127,358
-35,792
| -22% | -$979K | 0.45% | 91 |
|
|
2014
Q4 | $4.25M | Sell |
163,150
-1,778
| -1% | -$46.9K | 0.55% | 77 |
|
|
2014
Q3 | $4.24M | Sell |
164,928
-614
| -0.4% | -$15K | 0.59% | 68 |
|
|
2014
Q2 | $4.08M | Buy |
165,542
+518
| +0.3% | +$12.5K | 0.55% | 70 |
|
|
2014
Q1 | $4.07M | Sell |
165,024
-994
| -0.6% | -$22.9K | 0.56% | 73 |
|
|
2013
Q4 | $3.75M | Sell |
166,018
-2,734
| -2% | -$59.9K | 0.51% | 85 |
|
|
2013
Q3 | $3.55M | Sell |
168,752
-3,164
| -2% | -$66.5K | 0.55% | 74 |
|
|
2013
Q2 | $3.32M | Buy |
+171,916
| New | +$3.49M | 0.58% | 73 |
|
Other funds holding HRL
MPI
Punch & Associates Investment Management's HRL Position: Q2 2022 in Review
Punch & Associates Investment Management sold out of Hormel Foods (HRL) in Q2 2022, closing a stake of 111,598 shares — an estimated $5.75M sold.
Punch & Associates Investment Management first reported a position in HRL in Q2 2013 and held it in 36 quarters. The position peaked at $5.84M in Q4 2015. 673 funds tracked by Wall St. Rank hold HRL as of Q2 2022.
- Punch & Associates Investment Management reported no remaining Hormel Foods position as of Q2 2022 after selling out during the quarter.
- Punch & Associates Investment Management sold 111,598 Hormel Foods shares in Q2 2022, an estimated $5.75M.
- Punch & Associates Investment Management first reported a position in Hormel Foods in Q2 2013 and held it in 36 quarters.
- Punch & Associates Investment Management's Hormel Foods position peaked at $5.84M in Q4 2015.
- 673 funds tracked by Wall St. Rank held Hormel Foods as of Q2 2022.
Based on Punch & Associates Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.